CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
29.94 -0.09(-0.31%) NAV as on 28 Apr 2026
5.29 % 1 M
1.24 % 1 Y
21.95 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.15

As on 31 Mar, 2026
age-icon Age :

10 yrs 4 m

Since 28 12 ,2015
exit_load Exit Load :

0.25%

aum AUM :

1,229.42 Crs

lock_in Lock-in :

0.25% on or before 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.35

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Rajat Srivastava

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2026
Others 0.31 %
Equity 99.69 %

TOP HOLDINGS

Sun Pharmaceutical Industries...10.34 %
Abbott India Ltd.5.89 %
Divi's Laboratories Ltd.5.83 %
Healthcare Global Enterprises...5.39 %
Max Healthcare Institute Ltd.5.14 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs58.69
Hospital & Healthcare Services32.71
Pesticides & Agrochemicals4.53
Business Support2.64
Insurance0.62
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)17.1815.8825.0628.6428.10
Net Assets(Rs Crores) (as on 31-Mar-2026) 553.33 493.44 878.70 1183.65 1229.42
Scheme Returns(%)(Absolute)16.04-7.3157.4613.01-0.81
B'mark Returns(%)(Absolute)NANANANANA
Category Rank41/7567/7619/9020/10251/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.94-0.09(-0.31%)NAV As on 29 Apr, 202628-Dec-2015Inception Date1,229.42AUM In Cr.1.24%1Y21.95%3Y13.53%5Y11.19%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity39.81-0.08(-0.20%)NAV As on 29 Apr, 202613-Jul-2018Inception Date6,293.14AUM In Cr.6.82%1Y26.87%3Y16.30%5Y19.38%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity436.91-1.19(-0.27%)NAV As on 29 Apr, 202614-Jul-1999Inception Date4,063.64AUM In Cr.3.42%1Y24.66%3Y15.72%5Y15.84%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity40.220.07(0.18%)NAV As on 29 Apr, 202602-Jul-2018Inception Date2,753.72AUM In Cr.9.68%1Y23.91%3Y14.64%5Y19.45%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity31.650.11(0.35%)NAV As on 29 Apr, 202610-Jul-2019Inception Date858.87AUM In Cr.5.82%1Y22.83%3Y12.77%5Y18.44%Since Inception